Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by todaypartlycloudyon Jun 13, 2017 1:11pm
134 Views
Post# 26357234

RE:RE:RE:What the heck

RE:RE:RE:What the heckOf all the things that need to get done, Trump admin is going to focus on hurting (legitimite) MJ businesses? 75% of the public is against the Feds imposing fed law on states that have passed their own legislation. This is going to be a losing battle for them. 

To equate the opiate drug epidemic with MJ is assinine, and the vast majority of the public knows this, so I'm not too worried about this thing really getting legs.

Does anyone know when the California senate is set to vote on the bill that was passed in the lower house a little while back to bar state resources from being used to help federal agencies in going after legitimite MJ businesses? 


Leafs4Life wrote: Someone at scotiabank (house 85) sold 175k shares in 20 minutes. Not sure why but most of this move appears to be from one motivated seller. 

It's possible he was spooked by the news that Jeff Sessions asked congress to let him prosecute medical marijuana providers. You can see the story at the link below.

https://www.washingtonpost.com/news/wonk/wp/2017/06/13/jeff-sessions-personally-asked-congress-to-let-him-prosecute-medical-marijuana-providers/?hpid=hp_hp-more-top-stories_sessions-pot-wb-9am%3Ahomepage%2Fstory&utm_term=.6b926384433c

One other thing of note is Brad and Jim are in Vancouver today meeting with the team up here. We can expect a corporate update in the next couple of days. If not made public, I will share what I am told when I speak with them. 


Bullboard Posts